
1. Oncoimmunology. 2012 Sep 1;1(6):979-981.

Oncolytic adenoviruses: A potent form of tumor immunovirotherapy.

Cerullo V(1), Vähä-Koskela M, Hemminki A.

Author information: 
(1)Laboratory of Immunovirotherapy; University of Helsinki; Helsinki, Finland ;
Cancer Gene Therapy Group, Molecular Cancer Biology Program & Transplantation
Laboratory & Haartman Institute; University of Helsinki; Helsinki, Finland.

The therapeutic efficacy of oncolytic viruses including adenovirus has been
thought to depend mostly on direct viral destruction of tumor cells. However,
this view has changed with the discovery that oncolysis can also induce innate
and antigen-specific adaptive immunity against the tumor. Here we summarize our
findings from cancer patients.

DOI: 10.4161/onci.20172 
PMCID: PMC3489766
PMID: 23162778 

